Você fala Português? Interessado em nossos produtos Holotype HLA e HLA Twin? Então, junte-se a nós no nosso Webinar na quarta-feira, 22 de maio! Registre-se aqui:
Join us for our first Portuguese webinar to learn more about the Holotype HLA assay and HLA Twin software. It will be an introduction to the assay workflow as well as the software for HLA genotyping using NGS.
Summary:
As NGS makes its way to becoming the gold standard for High Resolution HLA Typing, Holotype HLA enables HLA laboratories to adopt a streamlined NGS workflow that also provides high flexibility, such as in the number of samples or loci one wants to process. HLA Twin, Omixon’s clinical-focused software, uses a traffic light system for simple data interpretation and streamlined workflow management. Join us in learning more about both Holotype HLA and HLA Twin.
Title: Introduction to Holotype HLA and HLA Twin / Apresentação em Português do Holotype HLA e HLA Twin | |
Date: | Wednesday, May 22, 2019 |
Time: | 11:00am – 12:00pm BRT (4:00pm–5:00pm CET / 3:00pm-4:00pm WET) |
(Webinar registration page is in Portuguese!)
Webinar Content
- Welcome by Ellia Gomes and Renata Santos
- Holotype HLA Presentation – Ellia Gomes
- HLA Twin Software Presentation – Renata Santos
- Live Q&A Session
Presenters
Ellia Gomes (Field Application Scientist, Omixon)
Ellia received a BSc degree in Molecular Biology and Bioinformatics degree from Towson University, MD. She is trilingual and speaks Portuguese, Spanish and English and worked at Johns Hopkins Immunogenetic Laboratory as a Histocompatibility technologist from 2010 until 2014. In that role, she performed highly complex clinical testing in support of solid organ, composite tissue, and bone marrow transplant programs. Ellia has been a Field Applications Scientist for Omixon for the past two years supporting the North and South American customers.
Renata Santos (Field Application Scientist, Omixon)
Renata received a BSc degree in Biomedical Sciences from Bridgewater State University, MA. Renata is bilingual, fluent in Portuguese and English and worked at Duke University Immunogenetic Laboratory as a Senior Histocompatibility Technologist for fives years. In that role, she performed highly complex clinical testing in support of solid organ, composite tissue, and bone marrow transplant programs. Renata has been in a Sales and Field Applications Scientist role for the past four year.